Anthony Butterworth | Academic Influence

Anthony Butterworth's AcademicInfluence.com Rankings

Anthony Butterworth

Biology

#10656

World Rank

#14003

Historical Rank

Immunology

#668

World Rank

#690

Historical Rank

biology Degrees

Download Badge

Biology

Anthony Butterworth's Degrees

Bachelors Biology University of Manchester
Masters Immunology University of Oxford
PhD Immunology University of Oxford

Similar Degrees You Can Earn

Best Online Bachelor's in Biology

Why Is Anthony Butterworth Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Anthony Butterworth FRS is a British immunologist. He worked for the Schistosomiasis Research Group at the University of Cambridge. His laboratory work is supplemented by field studies in sub-Saharan Africa, the Philippines, South America and the United States.

(See a Problem?)

Anthony Butterworth's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection (1992) (417)
Eosinophils as mediators of antibody-dependent damage to schistosomula (1975) (354)
Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. (1979) (348)
A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. (1979) (322)
Cell-mediated damage to helminths. (1984) (300)
Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. (1985) (254)
Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial (2010) (241)
Immunity to schistosomes: progress toward vaccine. (1987) (231)
High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. (1998) (214)
Role of IgE receptors in effector function of human eosinophils. (1984) (204)
Uptake of Workplace HIV Counselling and Testing: A Cluster-Randomised Trial in Zimbabwe (2006) (172)
Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni (1991) (170)
Effect of optional home initiation of HIV care following HIV self-testing on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial. (2014) (165)
Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils (1977) (161)
Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection (1993) (160)
Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns (1999) (159)
Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. (1985) (156)
IgA antibodies to a protective antigen in human Schistosomiasis mansoni. (1993) (151)
Epidemiology of Tuberculosis in a High HIV Prevalence Population Provided with Enhanced Diagnosis of Symptomatic Disease (2007) (144)
Functional study of a monoclonal antibody to IgE Fc receptor (Fc epsilon R2) of eosinophils, platelets, and macrophages (1986) (142)
Immunity in human schistosomiasis mansoni: prevention by blocking antibodies of the expression of immunity in young children (1987) (140)
Antibody-dependent cell-mediated damage to schistosomula in vitro (1974) (134)
Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. (1980) (132)
Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies (1986) (130)
Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. (1989) (123)
HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe (2007) (120)
Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. (2005) (120)
A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man (1995) (110)
Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children (2004) (105)
Immunity in human schistosomiasis. (1987) (103)
Immune evasion by Schistosoma mansoni: loss of susceptibility to antibody or complement-dependent eosinophil attack by schistosomula cultured in medium free of macromolecules (1981) (103)
Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment. (1984) (101)
Observations on possible immunity to reinfection among Kenyan schoolchildren after treatment for Schistosoma mansoni. (1983) (101)
On the use of age-intensity data to detect immunity to parasitic infections, with special reference to Schistosoma mansoni in Kenya (1992) (99)
Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment (1996) (97)
Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda. (2003) (96)
Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. (2009) (95)
Studies on the Mechanisms of Immunity in Human Schistosomiasis (1982) (94)
Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity (1991) (92)
Immunity in human schistosomiasis mansoni: cross-reactive IgM and IgG2 anti-carbohydrate antibodies block the expression of immunity. (1988) (89)
Longitudinal studies on human schistosomiasis. (1988) (88)
Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. (2010) (88)
Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: mediation by IgG, and inhibition by antigen-antibody complexes. (1977) (86)
Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates. (1997) (84)
Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control. (1992) (84)
Immunity and morbidity in human schistosomiasis mansoni. (1994) (82)
Cytotoxicity of human and baboon mononuclear phagocytes against schistosomula in vitro: induction by immune complexes containing IgE and Schistosoma mansoni antigens. (1978) (82)
Enhancement of human eosinophil-mediated killing of Schistosoma mansoni larvae by mononuclear cell products in vitro (1983) (81)
Eosinophil function. (1981) (81)
Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control. (2009) (78)
Spatial patterns of human water contact and Schistosoma mansoni transmission and infection in four rural areas in Machakos District, Kenya. (1997) (78)
Schistosomiasis and HIV-1 infection in rural Zimbabwe: implications of coinfection for excretion of eggs. (2005) (76)
Use of circulating cathodic antigen strips for the diagnosis of urinary schistosomiasis. (2009) (76)
Human antibody responses to Schistosoma mansoni: the influence of epitopes shared between different life‐cycle stages on the response to the schistosomulum (1988) (75)
Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis (2015) (73)
Polymorphisms in the tumor necrosis factor-alpha gene promoter may predispose to severe silicosis in black South African miners. (2002) (73)
Seroepidemiology and serodiagnosis of schistosomiasis in Kenya using crude and purified egg antigens of Schistosoma mansoni in ELISA. (1993) (73)
Human IgE responses to Schistosoma mansoni and resistance to reinfection. (1992) (72)
Schistosoma mansoni in the baboon (Papio anubis): parasitological responses of Kenyan baboons to different exposures of a local parasite strain (1976) (71)
The influence of sex and age on antibody isotype responses to Schistosoma mansoni and Schistosoma japonicum in human populations in Kenya and the Philippines (1997) (71)
Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptides (1990) (70)
Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis (2004) (69)
The adherence of human neutrophils and eosinophils to schistosomula: evidence for membrane fusion between cells and parasites (1980) (69)
Epidemiology and morbidity of Schistosoma mansoni infection in a fishing community along Lake Albert in Uganda. (2004) (67)
Development of Antibody Isotype Responses to Schistosoma mansoni in an Immunologically Naive Immigrant Population: Influence of Infection Duration, Infection Intensity, and Host Age (1999) (67)
The isolation of a 22 kDa band after SDS‐PAGE of Schistosoma mansoni adult worms and its use to demonstrate that IgE responses against the antigen(s) it contains are associated with human resistance to reinfection (1997) (66)
The mechansim of antibody-dependent, eosinophil-mediated damage to schistosomula of Schistosoma mansoni in vitro: a study by phase-contrast and electron microscopy. (1978) (66)
A comparison of direct microscopy, the concentration method and the Mycobacteria Growth Indicator Tube for the examination of sputum for acid-fast bacilli. (2003) (66)
Water contact observations in Kenyan communities endemic for schistosomiasis: methodology and patterns of behaviour (1996) (65)
Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against schistosomes. (1987) (65)
Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe. (2011) (65)
Immunity after treatment of human schistosomiasis mansoni. III. Long-term effects of treatment and retreatment. (1987) (61)
Vaccines against schistosomiasis: where do we stand? (1992) (55)
Reduced mortality and CD4 cell loss among carriers of the interleukin-10 −1082G allele in a Zimbabwean cohort of HIV-1-infected adults (2007) (55)
Morbidity in schistosomiasis: an update. (2004) (54)
Differences in the rate of hepatosplenomegaly due to Schistosoma mansoni infection between two areas in Machakos District, Kenya. (1991) (54)
The blocking of human antibody-dependent, eosinophil-mediated killing of Schistosoma mansoni schistosomula by monoclonal antibodies which cross-react with a polysaccharide-containing egg antigen (1987) (54)
The use of mouse/human chimaeric antibodies to investigate the roles of different antibody isotypes, including lgA2, in the killing of Schistosoma mansoni schistosomula by eosinophils (1993) (53)
Age-dependent reduction of schistosome fecundity in Schistosoma haematobium but not Schistosoma mansoni infections in humans. (1996) (51)
Immunoprecipitation of surface antigen precursors from Schistosoma mansoni messenger RNA in vitro translation products. (1984) (50)
Chronic cough in primary health care attendees, Harare, Zimbabwe: diagnosis and impact of HIV infection. (2005) (49)
Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni. (2005) (49)
Factors that modify the cellular-immune response in patients infected by Schistosoma mansoni. (1980) (48)
Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm (1997) (48)
Evidence for predisposition of individual patients to reinfection with Schistosoma mansoni after treatment. (1987) (48)
Cytolytic T lymphocytes recognize alloantigens on schistosomula of Schistosoma mansoni, but fail to induce damage. (1979) (48)
Nutritional status of children with schistosomiasis mansoni in two different areas of Machakos District, Kenya. (1992) (48)
Population-based differences in Schistosoma mansoni- and hepatitis C-induced disease. (2002) (47)
Associations between anti-Schistosoma mansoni and anti-Plasmodium falciparum antibody responses and hepatosplenomegaly, in Kenyan schoolchildren. (2003) (47)
Nursing and community rates of Mycobacterium tuberculosis infection among students in Harare, Zimbabwe. (2007) (47)
Clone banks of cDNA from the parasite Schistosoma mansoni: isolation of clones containing a potentially immunodiagnostic antigen gene. (1983) (46)
Immunological aspects of human schistosomiasis. (1998) (44)
Partial purification and biological properties of an eosinophil‐activating factor (1985) (42)
The Risk and Timing of Tuberculosis Diagnosed in Smear-Negative TB Suspects: A 12 Month Cohort Study in Harare, Zimbabwe (2010) (42)
A comparison of eosinophil‐activating factor (EAF) with other monokines and lymphokines (1986) (42)
Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection. (2006) (42)
Schistosomiasis mansoni in Kenya: relationship between infection and anaemia in schoolchildren at the community level. (1996) (41)
A new method for measuring eosinophil activating factors, based on the increased expression of CR3 alpha chain (CD11b) on the surface of activated eosinophils. (1990) (41)
Immunity and morbidity in Schistosoma mansoni infection: quantitative aspects. (1996) (40)
Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole. (1975) (40)
Mechanism of the interaction mediating killing of Schistosoma mansoni by human eosinophils. (1980) (39)
Schistosoma mansoni in baboons. Antibody-dependent cell-mediated damage to 51Cr-labelled schistosomula. (1976) (39)
Human immunity to Schistosomes: some questions. (1994) (39)
Polyparasitism in two rural communities with endemic Schistosoma mansoni infection in Machakos District, Kenya. (1995) (38)
Partial and complete detachment of neutrophils and eosinophils from schistosomula: evidence for the establishment of continuity between a fused and normal parasite membrane (1980) (38)
Antibody-dependent eosinophil-mediated damage to schistosomula of Schistosoma mansoni: lack of requirement for oxidative metabolism. (1981) (37)
Schistosoma mansoni in the Kenyan baboon (Papio anubis): the development and predictability of resistance to homologous challenge. (1978) (36)
Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations. (2000) (36)
Predisposition of humans to infection with Schistosoma mansoni: evidence from the reinfection of individuals following chemotherapy. (1988) (34)
Preliminary evaluation of some wild and cultivated plants for snail control in Machakos District, Kenya. (1987) (34)
Soluble antigens and antibodies in sera from baboons infected with Schistosoma mansoni. (1976) (34)
Antibody-dependent, eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: effect of metabolic inhibitors and other agents which alter cell function. (1977) (33)
Exposure to malaria affects the regression of hepatosplenomegaly after treatment for Schistosoma mansoni infection in Kenyan children (2004) (33)
Interactions between human eosinophils and schistosomula of Schistosoma mansoni. I. Stable and irreversible antibody-dependent adherence. (1980) (33)
The development of schistosomiasis mansoni in an immunologically naive immigrant population in Masongaleni, Kenya (1998) (31)
Morphological evidence for the ability of eosinophils to damage antibody-coated schistosomula. (1977) (31)
Cellular immune responses of a Senegalese community recently exposed to Schistosoma mansoni: correlations of infection level with age and inflammatory cytokine production by soluble egg antigen‐specific cells (1999) (30)
Long term study on the effect of mollusciciding with niclosamide in stream habitats on the transmission of schistosomiasis mansoni after community-based chemotherapy in Makueni District, Kenya (2013) (30)
Observations on the effects of different chemotherapy strategies on the transmission of Schistosoma mansoni in Machakos District, Kenya, measured by long-term snail sampling and cercariometry (1994) (30)
Identifying recent Mycobacterium tuberculosis transmission in the setting of high HIV and TB burden (2010) (28)
Kidney lesions in baboons infected with Schistosoma mansoni. (1977) (28)
Immunity after treatment of human schistosomiasis mansoni quantitative and qualitative antibody responses to tegumental membrane antigens prepared from adult worms. (1987) (26)
Human IgG subclass responses and subclass restriction to Schistosoma mansoni egg antigens. (1994) (26)
Prevalence and familial aggregation of schistosomal liver morbidity in Kenya: evaluation by new ultrasound criteria. (2001) (26)
Voluntary counseling and testing by nurse counselors: what is the role of routine repeated testing after a negative result? (2006) (25)
Identification of a human granulocyte functional antigen (GFA-2) involved in antibody-dependent cell-mediated cytotoxicity and phagocytosis. (1985) (25)
Immunology of schistosomiasis. (1990) (24)
Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasis. (2008) (23)
Maturation In Vivo of Schistosoma mansoni Schistosomula After Culture In Vitro with Granulocytes and Antibody (1983) (23)
Genetic influence on the antibody response to antigens of Schistosoma mansoni in chronically infected mice (1986) (21)
The detection of antibodies against Schistosoma mansoni soluble egg antigens (SEA) and CEF6 in ELISA, before and after chemotherapy (2003) (21)
Functional studies on purified eosinophils and neutrophils from patients with Schistosoma mansoni infections. (1980) (21)
Studies on the enhancement of human eosinophil function by mononuclear cell products in vitro. (1984) (20)
Effector mechanisms against schistosomes in vitro. (1977) (20)
Optimizing Outpatient Serial Sputum Colony Counting for Studies of Tuberculosis Treatment in Resource-Poor Settings (2012) (19)
Eosinophilia and eosinophil helminthotoxicity in patients treated for Schistosoma mansoni infections. (1991) (19)
IgG4 and IgE responses to Schistosoma mansoni adult worms after treatment. (1997) (19)
Coping with intestinal illness among the Kamba in Machakos, Kenya, and aspects of schistosomiasis control. (1987) (18)
Antibody isotype responses to the Schistosoma mansoni schistosomulum in the CBA/N mouse induced by different stages of the parasite life cycle (1990) (18)
Morbidity in schistosomiasis: assessment, mechanisms and control. (1998) (17)
Control of schistosomiasis in man. (1988) (16)
The control of schistosomiasis - is a vaccine necessary? (1987) (16)
Cytotoxic effects in vitro of human monocytes and macrophages on schistosomula of Schistosoma mansoni (1989) (15)
Cloning of the gene encoding a 50 kilodalton potential surface antigen of Schistosoma mansoni. (1988) (14)
Interpreting Tuberculin Skin Tests in a Population With a High Prevalence of HIV, Tuberculosis, and Nonspecific Tuberculin Sensitivity (2010) (14)
Immune responses during human schistosomiasis mansoni. II. Occurrence of eosinophil-dependent cytotoxic antibodies in relation to intensity and duration of infection. (1977) (14)
Models for Infectious Human Diseases: Some mathematical and statistical issues in assessing the evidence for acquired immunity to schistosomiasis (1996) (13)
Human immunodeficiency virus, smoking and self-rated health in Harare, Zimbabwe. (2006) (13)
The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils. (1986) (13)
Human antibody responses to Schistosoma mansoni: does antigen directed, isotype restriction result in the production of blocking antibodies? (1987) (12)
Molecular cloning of schistosome genes (1986) (11)
A survey of Schistosoma mansoni induced kidney disease in children in an endemic area of Machakos District, Kenya. (1994) (11)
Knowledge, perceptions and health behavior pertaining to Schistosoma mansoni related illness in Machakos district, Kenya. (1986) (11)
Studies on human schistosomiasis: chemotherapy, immunity and morbidity. (1990) (11)
Mechanisms of eosinophil mediated helminthotoxicity. (1980) (10)
Eosinophils and immunity to parasites (1980) (10)
Factors affecting the levels of antibody‐ and complement‐dependent eosinophil‐mediated damage to schistosomula of Schistosoma mansoni in vitro (1985) (9)
Monoclonal antibodies against surface antigens of schistosomula of Schistosoma mansoni. (1982) (9)
Antibody-Dependent Cell-Mediated Cytotoxicity in Cattle: Activity Against 51Cr-Labeled Chicken Erythrocytes Coated with Protozoal Antigens (1978) (9)
The presence of eosinophil‐activating mediators in sera from individuals with Schistosoma mansoni infections (1991) (8)
Major histocompatibility complex products restrict the adherence of cytolytic T lymphocytes to minor histocompatibility antigens or to trinitrophenyl determinants on schistosomula of Schistosoma mansoni. (1979) (8)
Morbidity in Schistosomiasis mansoni I (1992) (7)
Immunity ot Schistosoma mansoni: antibody-dependent eosinophil-mediated damage to schistosomula. (1977) (7)
Quality control of Kato slide counts for Schistosoma mansoni: a review of 12 years' experience in Kenya. (1997) (7)
Attempts to manipulate specific responses to induce resistance to Schistosoma mansoni in Kenyan baboons (Papio anubis) (1985) (7)
Eosinophilia in Kenyan baboons (Papio anubis) induced by Trichinella spiralis and Schistosoma mansoni (1977) (6)
Tuberculin sensitivity in kala-azar. (1981) (6)
Effect of drugs used in the treatment of asthma on the production of eosinophil-activating factor by monocytes. (1988) (6)
Heat-labile and heat-stable anti-schistosomular antibodies in Kenyan schoolchildren infected with Schistosoma mansoni. (1981) (6)
Immunity to schistosomes: advances and prospects. (1979) (6)
Significance of local formation of immune complexes within granulomata in schistosomiasis. (1979) (6)
HIV infection and the duration and control of prevalent tuberculosis disease in Harare, Zimbabwe (2005) (4)
Comparison of the ability of eosinophils and neutrophils, and of eosinophils from patients with S. mansoni infection and normal individuals, to mediate in vitro damage to schistosomula of S. mansoni. (1979) (4)
Immunosuppressive properties of a ribonuclease-containing fraction from bacterial cultures. (1972) (4)
Human macrophage-mediated cytotoxicity of Schistosoma mansoni. Functional and structural features of the effector cells. (1989) (4)
Blocking antibodies and vaccine strategy in schistosomiasis. (1987) (4)
Eosinophil-activating factor (EAF) production by a human cell line (ESH 98) stimulated with tumour necrosis factor. (1988) (3)
Surface proteins of the human eosinophil. II. Effects of Schistosoma mansoni larvae on eosinophil surface proteins. (1984) (3)
Genetic engineering and a schistosome vaccine. (1984) (3)
Eosinophil-mediated damage to larval schistosomes in vitro. (1980) (3)
Production of eosinophil-activating factor (EAF) by peripheral blood mononuclear cells from asthma patients. (1989) (3)
Morbidity in schistos mansoni I. (1992) (2)
Molecular cloning of schistosoma genes (1986) (2)
Lysosomes in immunity to schistosomes and other helminths. (1979) (2)
Failure of anti-Fasciola antisera to induce antibody-dependent, eosinophil-mediated killing of Schistosoma mansoni schistosomula. (1987) (2)
CHAPTER 20 – Immunological Studies on Schistosomes Cultured in Vitro (1979) (2)
Principles of Medicine in Africa: Schistosomiasis (2013) (1)
Increased binding of urease by activated eosinophils. Reassessment of an ELISA for CD11b. (1992) (0)
Quality control ofKatoslide countsfor Schistosoma mansoni: areview of12years' experience inKenya (1997) (0)
Contents, Vol. 90, 1989 (1989) (0)
HumanIgGsubclass responsesandsubclass restriction to Schistosoma mansoni eggantigens (1994) (0)
Optional Home Initiation of HIV Care Following HIV Self-testing on Antiretroviral Therapy Initiation Among Adults in Malawi: A Ran- (2018) (0)
Membrane fusion between polymorphonuclear leukocytes and schistosoma mansoni (1979) (0)
Isotype responses to native Schistosoma japonicum paramyosin: age-dependence of the human IgA response (1998) (0)
PAR volume 99 issue 3 Cover and Back matter (1989) (0)
PAR volume 105 issue 3 Cover and Front matter (1992) (0)
Long term study on the effect of mollusciciding with niclosamide in streamhabitats on the transmission of schistosomiasis mansoni after community-basedchemotherapy in Makueni District, Kenya (2013) (0)
Immunity in human schistosomiasis. (1987) (0)
Functional studies onpurified eosinophils andneutrophils from patients withSchistosoma mansoni infections (1980) (0)
PAR volume 102 issue 3 Cover and Back matter (1991) (0)
Major histocompatibility complex products restrict the adherence of cytolytic T lymphocytes to minor histocompatibility antigens or to trinitrophenyl determinants on schistosomula of Schistosoma mansoni ( H-2 restriction / antigen binding (0)
Human Schistosomiasis Mansoni IL-5 , Are Associated with Hepatosplenic Disease , but Low Levels of γ Soluble ICAM-1 , and IFN-High Levels of TNF , Soluble TNF Receptors (1998) (0)
PAR volume 105 issue 1 Cover and Front matter (1992) (0)
burden transmission in the setting of high HIV and TB Mycobacterium tuberculosis Identifying recent (0)
Eosinophils. A comprehensive review and guide to the scientific and medical literature: by Christopher J.F. Spry Oxford University Press, 1988. £(50.00 (xiii + 484 pages) ISBN 0 19 261408 8 (1989) (0)
Fractionation of Mononudear Cell Supernatants (2003) (0)
PAR volume 103 issue 3 Cover and Back matter (1991) (0)
PAR volume 104 issue 3 Cover and Back matter (1992) (0)
Correlates of prior HIV testing and schistosomiasis treatment: baseline survey findings from the "creating demand for fishermens schistosomiasis HIV services" (FISH) cluster-randomized trial in Mangochi, Malawi (2022) (0)
Tuberculin Sensitivity In Kala-azar. Transaction Of The Royal Society Of Tropical Medical And Hygiene (1981) (0)
PAR volume 95 issue 3 Cover and Back matter (1987) (0)
MONOCLONAL ANTIBODY TO THE SECOND lgE Fc RECEPTOR Washed human platelets (2003) (0)

This paper list is powered by the following services:

Other Resources About Anthony Butterworth

en.wikipedia.org

What Schools Are Affiliated With Anthony Butterworth?

Anthony Butterworth is affiliated with the following schools: